Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Mycobacterium bovis/ immunology"'
Autor:
Peter Aaby, Stefan H. E. Kaufmann, Peter R. Donald, Marcel A. Behr, Mihai G. Netea, Anna M. Mandalakas, Christoph Lange
Publikováno v:
Lancet Infectious Diseases, 22, e2-e12
Lange, C, Aaby, P, Behr, M A, Donald, P R, Kaufmann, S H E, Netea, M G & Mandalakas, A M 2022, ' 100 years of Mycobacterium bovis bacille Calmette-Guérin ', The Lancet Infectious Diseases, vol. 22, no. 1, pp. e2-e12 . https://doi.org/10.1016/S1473-3099(21)00403-5
Lancet Infectious Diseases, 22, 1, pp. e2-e12
Lange, C, Aaby, P, Behr, M A, Donald, P R, Kaufmann, S H E, Netea, M G & Mandalakas, A M 2022, ' 100 years of Mycobacterium bovis bacille Calmette-Guérin ', The Lancet Infectious Diseases, vol. 22, no. 1, pp. e2-e12 . https://doi.org/10.1016/S1473-3099(21)00403-5
Lancet Infectious Diseases, 22, 1, pp. e2-e12
Item does not contain fulltext Mycobacterium bovis bacille Calmette-Guérin (BCG), an experimental vaccine designed to protect cattle from bovine tuberculosis, was administered for the first time to a newborn baby in Paris in 1921. Over the past cent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aebbe46f3a07b8bfb8181c7c742e9e94
http://hdl.handle.net/2066/248701
http://hdl.handle.net/2066/248701
Autor:
Khatri G.R., Frieden Thomas R.
Publikováno v:
Bulletin of the World Health Organization, Vol 80, Iss 6, Pp 457-463 (2002)
Since late 1998 the coverage of the DOTS strategy in India has been expanded rapidly. In both 2000 and 2001 the country probably accounted for more than half the global increase in the number of patients treated under DOTS and by early 2002 more than
Externí odkaz:
https://doaj.org/article/0e40e3fdf37a4dbc8cfde1437f0ff2af
Autor:
Ginsberg Ann M.
Publikováno v:
Bulletin of the World Health Organization, Vol 80, Iss 6, Pp 483-488 (2002)
Over the past 10 years, tuberculosis (TB) vaccine development has resurged as an active area of investigation. The renewed interest has been stimulated by the recognition that, although BCG is delivered to approximately 90% of all neonates globally t
Externí odkaz:
https://doaj.org/article/88200bf76bc94e9da7ebb11f100ad0ce
Autor:
Christine Stabell Benn, Peter Aaby, Rob J.W. Arts, Susanne Dam Nielsen, Jesper Kjaergaard, Lone Graff Stensballe, Mihai G. Netea, Thomas Nørrelykke Nissen, Andreas Andersen, Nina Marie Birk, Poul-Erik Kofoed, Lisbeth Marianne Thøstesen, Dorthe Lisbeth Jeppesen, Morten Ruhwald, Bastiaan A. Blok, Ole Pryds, Thomas Hoffmann
Publikováno v:
European Journal of Clinical Microbiology and Infectious Diseases, 37, 1, pp. 29-41
Nissen, T N, Birk, N M, Blok, B A, Arts, R J W, Andersen, A, Kjærgaard, J, Thøstesen, L M, Hoffmann, T, Jeppesen, D L, Nielsen, S D, Kofoed, P-E, Stensballe, L G, Aaby, P, Ruhwald, M, Netea, M G, Benn, C S & Pryds, O 2018, ' Bacillus Calmette-Guérin vaccination at birth and in vitro cytokine responses to non-specific stimulation. A randomized clinical trial ', European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 37, no. 1, pp. 29–41 . https://doi.org/10.1007/s10096-017-3097-2
European Journal of Clinical Microbiology and Infectious Diseases, 37, 29-41
Nissen, T N, Birk, N M, Blok, B A, Arts, R J W, Andersen, A, Kjærgaard, J, Thøstesen, L M, Hoffmann, T, Jeppesen, D L, Nielsen, S D, Kofoed, P-E, Stensballe, L G, Aaby, P, Ruhwald, M, Netea, M G, Benn, C S & Pryds, O 2018, ' Bacillus Calmette-Guérin vaccination at birth and in vitro cytokine responses to non-specific stimulation. A randomized clinical trial ', European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 37, no. 1, pp. 29–41 . https://doi.org/10.1007/s10096-017-3097-2
European Journal of Clinical Microbiology and Infectious Diseases, 37, 29-41
Several studies have shown increased in vitro cytokine responses to non-related pathogens after Bacillus Calmette-Guérin (BCG) vaccination. A total of 158 infants (80 BCG administered within 7 days of birth; 78 controls) were bled 4 days post-random
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eca0d949a90097775cdc667e9297698
https://hdl.handle.net/2066/183783
https://hdl.handle.net/2066/183783
Autor:
Mehmood, Arshad, Kouser, Lubna, Kaur, Anuvinder, Holmskov, Uffe, Al-Ahdal, Mohammed N., Sim, Robert B., Kishore, Uday, Tsolaki, Anthony G.
Publikováno v:
Mehmood, A, Kouser, L, Kaur, A, Holmskov, U, Al-Ahdal, M N, Sim, R B, Kishore, U & Tsolaki, A G 2019, ' Complement dependent and independent interaction between bovince congultinin and mycobacterium bovis BCG : Implications in Bovine Tuberculosis. ', Frontiers in Immunology, vol. 9, 3159 . https://doi.org/10.3389/fimmu.2018.03159
Bovine conglutinin, the first animal collectin to be discovered, is structurally very similar to Surfactant Protein D (SP-D). SP-D is known to interact with Mycobacterium tuberculosis, and the closely-related M. bovis, the causative agent of bovine t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::75bed0497617f8b963db9465dcf2c15f
https://findresearcher.sdu.dk:8443/ws/files/156146218/Complement_dependent_and_independent_interaction_between_bovince_congultinin_and_mycobacterium_bovis_BCG.pdf
https://findresearcher.sdu.dk:8443/ws/files/156146218/Complement_dependent_and_independent_interaction_between_bovince_congultinin_and_mycobacterium_bovis_BCG.pdf
Autor:
Boillat-Blanco, N., Tumbo, A.N., Perreau, M., Amelio, P., Ramaiya, K.L., Mganga, M., Schindler, C., Gagneux, S., Reither, K., Probst-Hensch, N., Pantaleo, G., Daubenberger, C., Portevin, D.
Publikováno v:
Immunity, inflammation and disease, vol. 6, no. 2, pp. 345-353
The rising prevalence of Diabetes mellitus (DM) in high TB-endemic countries may adversely affect sustainability of TB control since DM constitutes a risk factor for development of active tuberculosis (TB). The impact of DM on TB specific adaptive im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::86068944d8028076819a7027c8d406da
https://edoc.unibas.ch/64652/
https://edoc.unibas.ch/64652/
Autor:
Jesper Kjaergaard, Nina Marie Birk, Poul-Erik Kofoed, Thomas Hoffmann, Lone Graff Stensballe, Gitte Thybo Pihl, Dorthe Lisbeth Jeppesen, Peter Aaby, Gorm Greisen, Thomas Nørrelykke Nissen, Lisbeth Marianne Thøstesen, Christine Stabell Benn, Ole Pryds
Publikováno v:
Nørrelykke Nissen, T, Birk, N M, Kjærgaard, J, Thøstesen, L, Thybo Pihl, G, Hoffmann, T, Jeppesen, D L, Kofoed, P-E, Greisen, G, Benn, C S, Aaby, P, Pryds, O & Stensballe, L G 2016, ' Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants : an evaluation of the Danish strain 1331 SSI in a randomized clinical trial ', Vaccine, vol. 34, no. 22, pp. 2477–2482 . https://doi.org/10.1016/j.vaccine.2016.03.100
Nissen, T N, Birk, N M, Kjærgaard, J, Thøstesen, L M, Pihl, G T, Hoffmann, T, Jeppesen, D L, Kofoed, P-E, Greisen, G, Benn, C S, Aaby, P, Pryds, O & Stensballe, L G 2016, ' Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial ', Vaccine, vol. 34, no. 22, pp. 2477-2482 . https://doi.org/10.1016/j.vaccine.2016.03.100
Nissen, T N, Birk, N M, Kjærgaard, J, Thøstesen, L M, Pihl, G T, Hoffmann, T, Jeppesen, D L, Kofoed, P-E, Greisen, G, Benn, C S, Aaby, P, Pryds, O & Stensballe, L G 2016, ' Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial ', Vaccine, vol. 34, no. 22, pp. 2477-2482 . https://doi.org/10.1016/j.vaccine.2016.03.100
OBJECTIVE: To evaluate adverse reactions of the Bacillus Calmette-Guérin (BCG) Statens Serum Institut (SSI) (Danish strain 1331) used as intervention in a randomized clinical trial.DESIGN: A randomized clinical multicenter trial, The Danish Calmette
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::782c78da5e5f584bd62e649795f61ef2
https://pubmed.ncbi.nlm.nih.gov/27060379
https://pubmed.ncbi.nlm.nih.gov/27060379
Autor:
Andreas Andersen, Gitte Thybo Pihl, Nina Marie Birk, Lone Graff Stensballe, Jesper Kjærgaard, Thomas Nørrelykke Nissen, Ole Pryds, Poul-Erik Kofoed, Lisbeth Marianne Thøstesen, Kim Thestrup Foss, Gorm Greisen
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0154541 (2016)
PLoS ONE
Kjærgaard, J, Stensballe, L G, Birk, N M, Nørrelykke Nissen, T, Foss, K T, Thøstesen, L, Thybo Pihl, G, Andersen, A, Kofoed, P-E, Pryds, O & Greisen, G 2016, ' Lack of a Negative Effect of BCG-Vaccination on Child Psychomotor Development : Results from the Danish Calmette Study-A Randomised Clinical Trial ', P L o S One, vol. 11, no. 4, e0154541 . https://doi.org/10.1371/journal.pone.0154541
PLoS ONE
Kjærgaard, J, Stensballe, L G, Birk, N M, Nørrelykke Nissen, T, Foss, K T, Thøstesen, L, Thybo Pihl, G, Andersen, A, Kofoed, P-E, Pryds, O & Greisen, G 2016, ' Lack of a Negative Effect of BCG-Vaccination on Child Psychomotor Development : Results from the Danish Calmette Study-A Randomised Clinical Trial ', P L o S One, vol. 11, no. 4, e0154541 . https://doi.org/10.1371/journal.pone.0154541
Objectives: To assess the non-specific effect of Bacillus Calmette-Guérin (BCG) vaccination at birth on psychomotor development. Design: This is a pre-specified secondary outcome from a randomised, clinical trial. Setting: Maternity units and paedia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d28cd1fa5ba03ee4aa75eef9ad2dd69
http://europepmc.org/articles/PMC4849633?pdf=render
http://europepmc.org/articles/PMC4849633?pdf=render
Autor:
D. Strebel, Cem Gabay, Gaby Palmer, Maria L. Olleros, Federica Sallusto, John E. Sims, Solenne Vigne, Francesca Ronchi, Dominique Vesin, Emiliana Rodriguez, Irene Garcia, Céline Lamacchia, Praxedis Martin
Publikováno v:
Blood
Blood, Vol. 120, No 17 (2012) pp. 3478-87
Blood, Vol. 120, No 17 (2012) pp. 3478-87
The interleukin-1 (IL-1) superfamily of cytokines comprises a set of pivotal mediators of inflammation. Among them, the action of IL-36 cytokines in immune responses has remained elusive. In a recent study, we demonstrated a direct effect of IL-36 on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a3713993e932703e0f7c1498aa9e389
Autor:
Anne-Françoise Rochat, Claire-Anne Siegrist, Karen Lingnau, Else Marie Agger, Arun T. Kamath, Paul-Henri Lambert, Mario Paolo Valenti, Alexander von Gabain, Peter Andersen
Publikováno v:
European Journal of Immunology, Vol. 38, No 5 (2008) pp. 1247-56
Vaccine efficacy largely depends upon DC targeting and activation. The most potent TLR soluble ligands induce diffuse DC activation, which may be associated with marked pro-inflammatory responses and possibly adverse effects. This raises the concern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c43873d7b578f338fce48c8a5441447
https://doi.org/10.1002/eji.200737889
https://doi.org/10.1002/eji.200737889